Year Joined

  • 2010

Areas of Expertise

  • Medical 

Boards Joined

  • WuXi AppTec Co., Ltd. 

Online Presence

GE IN THE NEWS

  • Ge Li ’s WuXi AppTech opens new factory in Massachusetts

    June 10, 2018  |  Forbes

  • Ge Li and wife Zhao Ning named honorary trustees of Peking University for $15 million alumni contribution

    June 12, 2018  |  Sina

  • Ge Li ’s WuXi Biologics aims for $513M IPO

    May 24, 2017  |  Endpoints News

  • Ge Li ’s Wuxi PharmaTech Acquires Biology Focused R&D Service Leader HD Biosciences Co.

    January 21, 2017  |  Biospace

  • Ge Li ’s Wuxi PharmaTech Acquires Biology Focused R&D Service Leader HD Biosciences Co.

    January 20, 2017  |  PR Newswire

  • Ge Li ’s WuXi PharmaTech receives Frost & Sullivan Asia Pacific Best Practices Awards

    December 29, 2016  |  Beijing Morning Post

  • Ge Li keynotes WuXi PharmaTech Life Chemistry Research Award Ceremony

    December 14, 2016  |  Huanqiu

  • Ge Li ’s WuXi AppTec launches non-invasive pre-pregnancy genetic screening product

    December 06, 2016  |  iFeng

  • Ge Li ’s medical and biotech platform company, WuXi AppTec, unveils manufacturing center for cutting edge cell and gene therapies

    October 06, 2016  |  PR Newswire

  • Ge Li ’s WuXi AppTech opens new factory in Massachusetts

    June 10, 2018  |  Forbes

  • Ge Li and wife Zhao Ning named honorary trustees of Peking University for $15 million alumni contribution

    June 12, 2018  |  Sina

  • Ge Li ’s WuXi Biologics aims for $513M IPO

    May 24, 2017  |  Endpoints News

  • Ge Li ’s Wuxi PharmaTech Acquires Biology Focused R&D Service Leader HD Biosciences Co.

    January 21, 2017  |  Biospace

  • Ge Li ’s Wuxi PharmaTech Acquires Biology Focused R&D Service Leader HD Biosciences Co.

    January 20, 2017  |  PR Newswire

  • Ge Li ’s WuXi PharmaTech receives Frost & Sullivan Asia Pacific Best Practices Awards

    December 29, 2016  |  Beijing Morning Post

  • Ge Li keynotes WuXi PharmaTech Life Chemistry Research Award Ceremony

    December 14, 2016  |  Huanqiu

  • Ge Li ’s WuXi AppTec launches non-invasive pre-pregnancy genetic screening product

    December 06, 2016  |  iFeng

  • Ge Li ’s medical and biotech platform company, WuXi AppTec, unveils manufacturing center for cutting edge cell and gene therapies

    October 06, 2016  |  PR Newswire

RELATED VIDEO

Ge Li Entrepeneur, Scientist, and leader in Tech R&D industry

李革

Founder, Chairman & CEO

WuXi AppTec Co., Ltd.

Dr.Ge Li is the Founder,Chairman and Chief Executive Officer of WuXi AppTec, a leading R&D capability and technology platform company serving the global pharmaceutical, biotechnology, and medical device industries with 11,000 employees and 24 R&D sites and offices worldwide.

An entrepreneur,a leader, and a scientist at heart, Dr. Li, named as one of “The 25 Most Influential People in Biopharma in 2015” by FierceBiotech, is working to lead the transformation of biopharma R&D with the conviction that more efficient and cost-effective R&D should be at the core of better medicines for patients.

A pioneer in biopharma R&D service industry in China, Dr. Li founded WuXi in December 2000 with four employees, China’s first modern chemistry hood, and a single 7,000-square-foot chemistry laboratory. During the past 15 years as its Chairman and CEO, Dr. Li has led WuXi’s rapid growth into a global R&D enabling powerhouse with a pioneering open-access platform as the cornerstone. Today, WuXi’s platform is enabling thousands of biopharma and medical device R&D programs from over 2000 collaborators worldwide,and has contributed to many partners’ successes:clinical milestones, successful IPOs, breakthrough designations, and blockbuster drugs that are profoundly improving patients’ lives.

Dr. Li’s visionary leadership and achievements have won him numerous prestigious awards and honors, including the “2016 OBA Brilliant Achievement Award”, “2015 SCRIP Executive of the Year Award”, “The 25 Most Influential People in Biopharma in 2015″,”Forbes 25 Notable Chinese-Americans”, “The 60 Most Influential People during 60 Years Pharmaceutical Development in China”,and “Ernst & Young Entrepreneur of the Year China Award”. WuXi has also received many distinguished recognition, including the “Asian CRO Company of the Year” Award (2015) ,the “North American Open-Access R&D Technology Leadership” Award (2015), “Best Company in an Emerging Market” (2014), “Deloitte Technology Fast 500 Asia Pacific” (2004-2009, 6 consecutive years), and “Fast Company 50 Most Innovative Companies” (2009).

Dr. Li earned his bachelor’s degree in Chemistry in 1989 from Peking University and his doctoral degree in Organic Chemistry from Columbia University in 1993. Prior to WuXi, Dr.Li was a founding scientist at Pharmacopeia Inc.,a leading combinatorial chemistry platform company.

Dr. Li is a co-author and co-inventor to over 100 scientific publications and issued or pending patents.

LATEST UPDATES

  • Committee of 100

    Extraordinary Chinese Americans

  • Ensuring Full Inclusion in America
    Advancing U.S.-China Relations
  • Connect
  • Contact
  • 257 Park Avenue South
    19th Fl.
    New York,NY 10010 Phone:212-371-6565
    Fax:212-371-9009

    c100@committee100.org

  • Sign Up For Updates